Evidence (2966 claims)
Adoption
8570 claims
Productivity
7631 claims
Governance
6869 claims
Human-AI Collaboration
6491 claims
Org Design
4175 claims
Innovation
4114 claims
Labor Markets
3566 claims
Skills & Training
2966 claims
Inequality
2066 claims
Evidence Matrix
Claim counts by outcome category and direction of finding.
| Outcome | Positive | Negative | Mixed | Null | Total |
|---|---|---|---|---|---|
| Other | 758 | 199 | 100 | 900 | 2007 |
| Governance & Regulation | 826 | 400 | 191 | 122 | 1563 |
| Organizational Efficiency | 777 | 193 | 124 | 84 | 1189 |
| Technology Adoption Rate | 635 | 233 | 124 | 97 | 1098 |
| Research Productivity | 422 | 128 | 57 | 336 | 954 |
| Output Quality | 476 | 179 | 59 | 47 | 761 |
| Decision Quality | 328 | 177 | 81 | 47 | 640 |
| Firm Productivity | 435 | 57 | 88 | 20 | 606 |
| AI Safety & Ethics | 218 | 277 | 65 | 33 | 599 |
| Market Structure | 180 | 170 | 123 | 24 | 502 |
| Task Allocation | 213 | 64 | 72 | 33 | 387 |
| Skill Acquisition | 170 | 61 | 61 | 17 | 309 |
| Innovation Output | 203 | 27 | 43 | 18 | 292 |
| Employment Level | 105 | 54 | 107 | 13 | 281 |
| Fiscal & Macroeconomic | 131 | 69 | 43 | 26 | 276 |
| Consumer Welfare | 117 | 63 | 42 | 11 | 233 |
| Firm Revenue | 153 | 48 | 26 | 3 | 230 |
| Task Completion Time | 173 | 31 | 8 | 12 | 225 |
| Inequality Measures | 44 | 122 | 49 | 6 | 221 |
| Worker Satisfaction | 89 | 65 | 22 | 12 | 188 |
| Error Rate | 69 | 92 | 10 | 2 | 173 |
| Regulatory Compliance | 77 | 69 | 14 | 5 | 165 |
| Automation Exposure | 56 | 56 | 26 | 13 | 154 |
| Training Effectiveness | 94 | 21 | 13 | 19 | 149 |
| Wages & Compensation | 77 | 36 | 25 | 6 | 144 |
| Team Performance | 86 | 17 | 27 | 10 | 141 |
| Developer Productivity | 95 | 17 | 14 | 6 | 133 |
| Job Displacement | 12 | 80 | 20 | 1 | 113 |
| Hiring & Recruitment | 52 | 7 | 8 | 3 | 70 |
| Creative Output | 31 | 18 | 8 | 3 | 61 |
| Skill Obsolescence | 5 | 46 | 6 | 1 | 58 |
| Social Protection | 27 | 16 | 8 | 2 | 53 |
| Labor Share of Income | 17 | 19 | 17 | — | 53 |
| Worker Turnover | 11 | 12 | — | 3 | 26 |
| Industry | — | — | — | 1 | 1 |
Skills Training
Remove filter
HACL/CS reduces omission rates (missed detections) in the simulated scenarios.
Omission/error rates were tracked and compared between conditions in the simulated testbed; summary claims reduction in omissions with HACL assistance but does not report numeric effect sizes or significance.
HACL/CS reduces time-to-decision in the simulated maritime surveillance tasks.
Measured time-to-classify in simulation under human-alone vs HACL-assisted conditions; summary indicates reductions in time-to-decision but lacks detailed statistics in the provided description.
In the simulated Canadian Arctic maritime surveillance domain, HACL/CS shows promise for improving classification accuracy.
Performance comparison between human-alone and HACL-assisted conditions in the maritime surveillance simulation measuring classification accuracy; summary reports improvement but does not provide sample size or significance levels.
Adjustable autonomy via self-confidence thresholds enables the system to act autonomously on high-certainty predictions and defer to humans on low-certainty cases.
System design feature of Cognitive Shadow implemented in simulation: autonomy decision rule based on meta-model confidence thresholds; behavior demonstrated in human-in-the-loop scenarios.
The Cognitive Shadow toolkit quantifies AI reliability with an empirical (0–1) confidence metric produced by a recursive meta-model.
Design and implementation detail: primary supervised models are paired with a recursive meta-model that predicts the primary model's reliability per situation and outputs a 0–1 empirical confidence score; applied in the simulated testbed.
Implementing an adaptive command-and-control process augmented by AI metacognition (the Cognitive Shadow toolkit) aligns AI judgments with expert human decision patterns.
Cognitive Shadow (CS) implemented as supervised ML models trained to mimic expert human decisions in the simulated maritime scenarios; alignment assessed by comparing model outputs to human expert decisions during human-in-the-loop interaction (implementation validated in simulation).
Human-AI co-learning (HACL) improves human-autonomy teaming (HAT) effectiveness.
Evaluated in a simulated Canadian Arctic maritime surveillance testbed using human-in-the-loop experiments comparing human-alone vs HACL-assisted conditions; exact participant sample size and statistical details not provided in the summary.
Self-directed autonomous agents (those that autonomously generated prompts and selected tools) bypassed human prompting failures and outperformed most human teams on the challenge set.
Comparative analysis of the four autonomous agents' trajectories, tool use, and success rates versus the 41 human participants/teams on the same fresh challenges; observed correlation between autonomous self-direction and higher success relative to most teams.
Trust in AI should be conceptualized as a socio-technical, team-level mechanism (trust calibration) that mediates between AI design/enablers and downstream collaboration and performance, rather than an individual-level stable attitude.
Theoretical synthesis combining findings from the thematic analysis of 40 interviews with socio-technical systems theory (STS) and adaptive structuration theory (AST) to propose an initial and revised conceptual model linking enablers → trust-calibration practices → collaboration dynamics → performance.
Five enablers support effective trust calibration: transparency/explainability, clear role definitions, good user experience (UX), supportive cultural norms, and timely system feedback.
Synthesized from recurring themes in the interview data (N=40) where respondents identified these factors as facilitating appropriate reliance on AI in project settings; coded and aggregated through thematic analysis.
Performance and reward structures must be redesigned to value oversight, hypothesis testing, escalation and governance behaviours that mitigate model risk but may not immediately increase output.
Managerial recommendation derived from the framework and organizational reward literature; no empirical evaluation provided.
Firms need new metrics to decompose value created by humans, AI, and their interaction (to distinguish complementarities versus substitution).
Analytic implication derived from the framework and literature on productivity measurement; presented as a recommendation for empirical work rather than tested evidence.
Symbiarchic leadership is a practical, HR‑oriented framework for leading integrated human–AI “cyber teams,” specifying four linked leadership practices that make AI a co‑actor in knowledge work while preserving human judgement, accountability and organizational legitimacy.
Paper's central proposition based on theoretical synthesis of academic literature on human–AI collaboration, hybrid teams and digital‑era leadership plus illustrative practitioner examples; no original empirical data or experiments.
Recommendations for policy include investing in public data infrastructure and standards, promoting regulatory clarity for AI validation, and supporting equitable access to AI-driven innovations.
Policy recommendations derived from synthesis of challenges and potential remedies presented in the narrative review; based on conceptual policy analysis and examples rather than empirical testing of interventions.
Policies that incentivize interoperable, privacy-preserving data sharing (e.g., federated data, common standards) can reduce entry barriers and improve social returns from AI in drug R&D.
Policy analysis and recommendations from the review, supported by conceptual arguments and examples of federated/privacy-preserving platforms; limited empirical validation of large-scale impact.
AI has the potential to raise R&D productivity by shortening timelines and reducing certain failure modes, thereby increasing the net present value (NPV) of successful drug projects.
Economic reasoning and projections based on documented process improvements in the reviewed studies and reports; not validated by longitudinal, generalized financial analyses in the literature.
AI enhances post-market safety signal detection using real-world data analytics.
Industry and regulatory reports and published studies in the review documenting improved detection or earlier identification of safety signals in pharmacovigilance applications using ML on real-world datasets.
AI-enabled adaptive and enrichment trial designs increase trial efficiency and statistical power.
Methodological studies, clinical-trial case studies, and regulatory guidance summarized in the review showing applications of ML to adaptive/enrichment designs; evidence mainly illustrative and context-specific.
AI improves predictive toxicity and ADMET models, which can reduce late-stage failures.
Multiple empirical studies and industry case reports aggregated in the narrative review demonstrating improved in silico toxicity/ADMET prediction performance in specific settings; heterogeneity across datasets and endpoints; not a formal meta-analysis.
AI can reduce time-to-market and lower some drug development costs.
Synthesis of case studies, industry reports, and empirical studies reported in the narrative review that document examples of compressed timelines and cost savings in parts of the pipeline; review notes lack of long-run, generalized ROI estimates.
AI is materially accelerating discovery and development steps in pharmaceutical R&D, improving target identification, lead optimization, safety prediction, and adaptive trial design.
Narrative review synthesizing published studies, review articles, industry and regulatory reports; evidence primarily consists of empirical studies and case studies covering preclinical and clinical-stage applications. No pooled quantitative meta-analysis; heterogeneous methods and therapeutic areas.
Firms with superior proprietary data and integration capability gain competitive advantage, increasing firm-level heterogeneity in AI returns.
Narrative analysis of market structure implications and examples; no cross-firm empirical heterogeneity study included.
Returns to complementary investments (data infrastructure, experiment automation, cross-disciplinary teams) increase as AI becomes more central to discovery workflows.
Synthesis of adoption lessons and case examples emphasizing complementary capital; no quantitative ROI estimates provided.
Embedding AI into organizational processes, decision-making, and wet-lab validation is crucial to capturing its value.
Narrative review of adoption and integration lessons from large biopharma experience and illustrative case studies.
Successful AI adoption requires investment in data, talent, and workflows rather than reliance on bolt-on point solutions.
Thematic analysis of adoption-level lessons and industry case examples indicating organizational and infrastructural requirements for realized value.
AI has produced genuine early-stage breakthroughs in drug discovery, accelerating hit identification and early design cycles.
Narrative expert synthesis and thematic analysis of industry experience over the first decade of AI adoption, illustrated by early-case successes and firm-reported accelerations; no new primary experimental data or causal econometric estimates provided.
Public policies that lower frictions for secure data sharing, standardize validation metrics, and support workforce retraining can accelerate beneficial diffusion of AI while managing risks.
Policy recommendation based on the paper's synthesis of enablers and constraints; not empirically tested within the paper.
AI has the potential to reduce marginal cost and time per candidate (shorter design loops, in silico screening), increasing effective productivity of R&D spend if improvements are validated.
Theoretical and conceptual argument referencing capabilities of generative models and simulation; paper states no new quantitative estimates were produced.
Workforce upskilling and new roles (e.g., ML engineers embedded in biology teams, AI product managers) are required for effective AI integration in pharma R&D.
Descriptive projection based on observed industry hiring trends and organizational needs; no workforce survey data provided.
Cloud/federated approaches reduce upfront infrastructure investments and facilitate distributed collaboration.
Conceptual argument based on cloud economics and federated architectures; no quantitative cost-savings or collaboration metrics presented.
Cloud and federated approaches enable access to powerful pre-trained or fine-tunable models while allowing proprietary data to remain controlled (privacy-preserving sharing and model-to-data patterns).
Technological synthesis and examples of federated learning and cloud-hosted ML patterns; no empirical performance or privacy-utility tradeoff measurements reported.
Startups can leverage pre-trained models, cloud compute, and hosted toolchains to compete on speed and niche innovation against larger incumbents.
Conceptual observation and illustrative examples; not supported by systematic comparison of startup vs incumbent performance metrics in the paper.
AI lowers entry costs for smaller biotech by enabling faster molecular design, simulation, and iteration, allowing earlier translation to clinical stages.
Argument grounded in current capabilities (pre-trained models, cloud compute) and illustrative startup examples; no empirical cost or time-to-clinic data provided.
Production-first democratization builds user-friendly, productionized AI tools that non-specialists can use, decentralizing model use and accelerating throughput.
Narrative examples and conceptual reasoning in the editorial; lacks systematic evaluation of throughput gains or decentralization effects.
Culture-centric transformation embeds AI into everyday scientific and operational decisions and requires organizational change, incentives, and cross-functional workflows.
Conceptual argument and organizational theory applied in the editorial; no empirical measurement of organizational change or success rates provided.
Partnership-driven acceleration lets pharma access AI capabilities rapidly via alliances with AI/tech firms while allowing pharma to preserve focus on core drug expertise and outsource model or platform development.
Qualitative description and illustrative examples in the editorial; not supported by systematic case study data or quantified outcomes.
Regulators should anticipate new forms of intangible capital and data monopolies arising from sensory models and consider standards for data interoperability, public datasets/models, and workforce retraining.
Policy recommendation based on foresight and literature on data governance and platform regulation; no empirical regulatory impact analysis provided.
Economics of AI in food must incorporate non-price metrics (perceptual quality, cultural fit) and design ways to monetize and protect sensory intellectual property (trade secrets, data governance).
Normative policy and methodological recommendation derived from literature synthesis and conceptual analysis; not validated with empirical economic valuation studies.
Interdisciplinary approaches (cognitive science, behavioral economics, design thinking) are necessary to capture the social, perceptual, and cultural dimensions of food experience.
Normative argument supported by literature synthesis across relevant disciplines; no experimental comparison of mono- vs interdisciplinary approaches provided.
Treating food as a soft-matter system centered on rheology provides a bridge from molecular/structural properties to macroscopic sensory experience.
Conceptual and theoretical argument grounded in soft-matter science and rheology literature; interdisciplinary literature synthesis; no new empirical data or experiments reported.
The study discovers a three-dimensional model for measuring performance, including AI Tool Mastery, Collaborative Work Quality, and Human-AI Synergy to measure hybrid skills developed through human-machine collaboration.
Model development derived from systematic analysis of the collected data (5,000 LinkedIn job adverts and 2,000 Indeed salary records, 2022–2024) and theorizing about dimensions needed to capture hybrid human-AI skills; the paper reports these three dimensions as its measurement model.
AI-trained staff are rewarded with a 17.7% overall premium for their wages.
Analysis of 2,000 Indeed salary data records from 2022–2024, comparing salaries for roles or incumbents identified as having AI training/skills versus those without.
The need for AI skills has grown at a rate of 376% since the release of ChatGPT.
Temporal comparison within the dataset of LinkedIn job adverts from 2022–2024 (5,000 adverts), comparing pre- and post-ChatGPT frequencies of AI-skill mentions to compute growth rate.
AI skills are especially needed in 27.8% of knowledge workers' jobs.
Systematic analysis of 5,000 LinkedIn job adverts collected between 2022–2024, where job postings were coded for AI-skill requirements, yielding the reported percentage.
Dynamic feedback loops create reinforcing organisational learning cycles.
Theoretical assertion from the paper's synthesis indicating learning dynamics as part of the model; described conceptually without empirical quantification in the abstract.
Complementarity–trust interaction determines optimal performance when high capability utilisation combines with appropriate trust levels.
Mechanistic claim from the TCM‑CI derived via systematic review/synthesis of existing studies; no primary experimental or field sample reported in the abstract to validate this interaction effect.
Calibrated trust maximises collective intelligence by balancing appropriate reliance with necessary oversight.
Core mechanism asserted by the paper based on synthesis of prior research in human–AI interaction and trust literature; presented as a conceptual mechanism rather than tested empirically in the abstract.
The Trust–Complementarity Model of Collective Intelligence (TCM‑CI) explains how calibrated trust and complementary capability utilisation drive superior organisational performance.
Theoretical model proposed by the authors derived from systematic literature synthesis (conceptual/modeling contribution); abstract does not report empirical validation or sample size.
Digital skills have surpassed traditional educational attainment to become a core human-capital element determining labor market performance in South Korea.
Interpretation based on regression results from the extended Mincerian wage equation applied to KLIPS micro-data showing sizable and significant wage premiums for digital skills even after controlling for years of education and other covariates.
For graduates of Technical and Vocational Education and Training (TVET), acquiring advanced digital skills significantly narrows the income gap with general higher education graduates.
Heterogeneity analysis on KLIPS micro-data examining interaction of educational pathway (TVET vs general higher education) with possession of advanced digital skills in extended Mincerian wage regressions; the result reported is a significant narrowing of the earnings gap (no numeric magnitude given in the excerpt).